GHDX - Genomic Health - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

Genomic Health's activity chart (see below) currently has 42 price targets and 23 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 77.5% of the time, taking 230.43 days on average.

Most recent stock forecast was given by MARK MASSARO from BTIG on 30-Jul-2019. First documented stock forecast 31-May-2013.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-Feb-2016

$72

$77

7 years 3 months 23 days ago
(30-Jul-2019)

5/8 (62.5%)

$-2 (-2.70%)

391

Buy Since 03-Jan-2019

$69

7 years 3 months 23 days ago
(30-Jul-2019)

2/4 (50%)

$14.75 (27.19%)

61

Sell Since 29-Jul-2019

$72

$25

7 years 3 months 24 days ago
(29-Jul-2019)

1/2 (50%)

$-1.07 (-1.46%)

7

Hold Since 11-Feb-2016

$72

$72

7 years 5 months 2 days ago
(20-Jun-2019)

4/5 (80%)

$16.88 (30.62%)

99

Buy Since 18-Jun-2013

$55

$38

7 years 5 months 23 days ago
(30-May-2019)

4/4 (100%)

$2 (3.77%)

841

Show more analysts

Please expand the browser size to see the chart

What is GHDX (Genomic Health) average time for price targets to be met?

On average it took 230 days for the stock forecasts to be reached, with an average price target met ratio of 77.5%.

Which analyst most recently updated their price target on GHDX (Genomic Health)?

Mark Massaro

Which analyst has the lowest performance score on GHDX (Genomic Health) with a proven track record?

TYCHO PETERSON

Which analyst has the most public recommendations on GHDX (Genomic Health)?

Mark Massaro works at BTIG and has 11 price targets and 8 ratings on GHDX

Which analyst is the currently most bullish on GHDX (Genomic Health)?

Mark Massaro with the highest potential upside of $8.56

Which analyst is the currently most reserved on GHDX (Genomic Health)?

Brandon Couillard with the lowest potential downside of -$38.44
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?